Status and phase
Conditions
Treatments
About
The drug-drug interaction study has been designed to investigate the effect of Fluvoxamine, Itraconazole and Paroxetine on the pharmacokinetics of ASN51
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Key Exclusion Criteria:
Note: Other protocol defined Inclusion/Exclusion criteria may apply
Primary purpose
Allocation
Interventional model
Masking
48 participants in 4 patient groups
Loading...
Central trial contact
Rolf Pokorny, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal